GGrantIndex
← Search

mda-9/svntenin: A Novel Diagnostic Marker and a Therapeutic Target for Metastatic

$32,200P30FY2006ARNIH

Columbia University Health Sciences, New York NY

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
mda-9/svntenin: A Novel Diagnostic Marker and a Therapeutic Target for Metastatic · GrantIndex